Ratings ChenGuang Biotech Group Co., Ltd.

Equities

300138

CNE100000WC5

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 07/05/2024 am IST			5-day change	1st Jan Change
9.97 ^CNY	+2.05%		+5.50%	-25.76%

24/04	ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24/04	ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback.	CI

Strengths

With a P/E ratio at 13.52 for the current year and 8.05 for next year, earnings multiples are highly attractive compared with competitors.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Over the past four months, analysts' average price target has been revised downwards significantly.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Food Processing

	1st Jan change	Capi.	ESG Refinitiv
CHENGUANG BIOTECH GROUP CO., LTD.	-25.76%	708M	-
NESTLÉ S.A.	-5.49%	266B	A-
MONDELEZ INTERNATIONAL, INC.	-2.13%	95.09B	C+
KRAFT HEINZ	-3.16%	43.48B	C+
DANONE	+0.07%	40.63B	B-
THE HERSHEY COMPANY	+6.29%	40.07B	B-
GENERAL MILLS, INC.	+7.32%	39.47B	B-
ARCHER-DANIELS-MIDLAND COMPANY	-14.72%	30.45B	B-
NESTLÉ INDIA LIMITED	-5.02%	28.98B	A
ASSOCIATED BRITISH FOODS PLC	+13.52%	25.18B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes